Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 265798, 12 pages
http://dx.doi.org/10.1155/2015/265798
Research Article

Ouabain Modulates Zymosan-Induced Peritonitis in Mice

1Instituto de Ciências Biomédicas, Departamento de Farmacologia, Laboratório de Neurofarmacologia Molecular, Universidade de São Paulo, 05508-900 São Paulo, SP, Brazil
2Centro de Biotecnologia, Laboratório de Imunofarmacologia, Programa de Pós-Graduação em Fisiologia Multicêntrico, Universidade Federal da Paraíba, 58059-900 João Pessoa, PB, Brazil
3Instituto de Bioquímica Médica Leopoldo de Meis, Laboratório de Imunologia Tumoral, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, RJ, Brazil
4Laboratório de Biologia do Sistema Imune, Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, RJ, Brazil
5Centro de Ciências da Saúde, Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos, Universidade Federal da Paraíba, 58059-900 João Pessoa, PB, Brazil

Received 20 March 2015; Accepted 22 April 2015

Academic Editor: Elzbieta Kolaczkowska

Copyright © 2015 Jacqueline Alves Leite et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Blaustein, J. Zhang, L. Chen et al., “The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension,” Hypertension, vol. 53, no. 2, pp. 291–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Y. Bagrov and J. I. Shapiro, “Endogenous digitalis: pathophysiologic roles and therapeutic applications,” Nature Clinical Practice Nephrology, vol. 4, no. 7, pp. 378–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Schoner and G. Scheiner-Bobis, “Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth,” American Journal of Physiology—Cell Physiology, vol. 293, no. 2, pp. 509–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Laredo, B. P. Hamilton, and J. M. Hamlyn, “Ouabain is secreted by bovine adrenocortical cells,” Endocrinology, vol. 135, no. 2, pp. 794–797, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Bauer, J. Müller-Ehmsen, U. Krämer et al., “Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition,” Hypertension, vol. 45, no. 5, pp. 1024–1028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Goto, K. Yamada, H. Nagoshi, Y. Terano, and M. Omata, “Stress-induced elevation of ouabainlike compound in rat plasma and adrenal,” Hypertension, vol. 26, no. 6, pp. 1173–1176, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Schoner, “Ouabain, a new steroid hormone of adrenal gland and hypothalamus,” Experimental and Clinical Endocrinology & Diabetes, vol. 108, no. 7, pp. 449–454, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Rodrigues-Mascarenhas, A. D. S. de Oliveira, N. D. Amoedo, O. R. Affonso-Mitidieri, F. D. Rumjanek, and V. M. Rumjanek, “Modulation of the immune system by ouabain,” Annals of the New York Academy of Sciences, vol. 1153, pp. 153–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Olej, N. F. dos Santos, L. Leal, and V. M. Rumjanek, “Ouabain induces apoptosis on PHA-activated lymphocytes,” Bioscience Reports, vol. 18, no. 1, pp. 1–7, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. V. L. G. de Moraes, B. Olej, L. de la Rocque, and V. M. Rumjanek, “Lack of sensitivity to ouabain in natural killer activity,” The FASEB Journal, vol. 3, no. 12, pp. 2425–2429, 1989. View at Google Scholar · View at Scopus
  11. M. Szamel and K. Resch, “Inhibition of lymphocyte activation by ouabain. Interference with the early activation of membrane phospholipid metabolism,” Biochimica et Biophysica Acta, vol. 647, no. 2, pp. 297–301, 1981. View at Google Scholar · View at Scopus
  12. S. R. Mascarenhas, J. Echevarria-Lima, N. F. dos Santos, and V. M. Rumjanek, “CD69 expression induced by thapsigargin, phorbol ester and ouabain on thymocytes is dependent on external Ca2+ entry,” Life Sciences, vol. 73, no. 8, pp. 1037–1051, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Rodrigues-Mascarenhas, F. F. Bloise, J. Moscat, and V. M. Rumjanek, “Ouabain inhibits p38 activation in thymocytes,” Cell Biology International, vol. 32, no. 10, pp. 1323–1328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Rodrigues-Mascarenhas, N. F. D. Santos, and V. M. Rumjanek, “Synergistic effect between ouabain and glucocorticoids for the induction of thymic atrophy,” Bioscience Reports, vol. 26, no. 2, pp. 159–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. P. Teixeira and V. M. Rumjanek, “Ouabain affects the expression of activation markers, cytokine production, and endocytosis of human monocytes,” Mediators of Inflammation, vol. 2014, Article ID 760368, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. Nascimento, R. C. Valente, J. Echevarria-Lima et al., “The influence of Ouabain on human dendritic cells maturation,” Mediators of Inflammation, vol. 2014, Article ID 494956, 15 pages, 2014. View at Publisher · View at Google Scholar
  17. P. L. Jacob, J. A. Leite, A. K. A. Alves et al., “Immunomodulatory activity of ouabain in Leishmania leishmania amazonensis-infected Swiss mice,” Parasitology Research, vol. 112, no. 3, pp. 1313–1321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. I. B. De Vasconcelos, J. A. Leite, L. T. Carneiro et al., “Anti-inflammatory and antinociceptive activity of ouabain in mice,” Mediators of Inflammation, vol. 2011, Article ID 912925, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Bereta, M. C. Cohen, and M. Bereta, “Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-κB,” FEBS Letters, vol. 377, no. 1, pp. 21–25, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Sowa and R. Przewłocki, “Ouabain enhances the lipopolysaccharide-induced nitric oxide production by rat peritoneal macrophages,” Immunopharmacology, vol. 36, no. 1, pp. 95–100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Matsumori, K. Ono, R. Nishio et al., “Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain,” Circulation, vol. 96, no. 5, pp. 1501–1506, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama, “Amlodipine inhibits the production of cytokines induced by ouabain,” Cytokine, vol. 12, no. 3, pp. 294–297, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Cash, G. E. White, and D. R. Greaves, “Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation,” Methods in Enzymology, vol. 461, pp. 379–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. N. Ajuebor, L. Virág, R. J. Flower, M. Perretti, and C. Szabó, “Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation,” Immunology, vol. 95, no. 4, pp. 625–630, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. N. S. Doherty, P. Poubelle, P. Borgeat, T. H. Beaver, G. L. Westrich, and N. L. Schrader, “Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2,” Prostaglandins, vol. 30, no. 5, pp. 769–789, 1985. View at Google Scholar · View at Scopus
  27. M. N. Ajuebor, A. M. Das, L. Virág, R. J. Flower, C. Szabó, and M. Perretti, “Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10,” Journal of Immunology, vol. 162, no. 3, pp. 1685–1691, 1999. View at Google Scholar · View at Scopus
  28. E. Kolaczkowska, R. Seljelid, and B. Plytycz, “Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice,” Journal of Leukocyte Biology, vol. 69, no. 1, pp. 33–42, 2001. View at Google Scholar · View at Scopus
  29. E. Kolaczkowska, “Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes,” Inflammation Research, vol. 51, no. 11, pp. 519–521, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Kolaczkowska, S. Shahzidi, R. Seljelid, N. Van Rooijen, and B. Plytycz, “Early vascular permeability in murine experimental peritonitis is comediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes,” Inflammation, vol. 26, no. 2, pp. 61–71, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Kolaczkowska, B. Arnold, and G. Opdenakker, “Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils,” Immunobiology, vol. 213, no. 2, pp. 109–124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Kolaczkowska, A. Koziol, B. Plytycz, and B. Arnold, “Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis,” Immunobiology, vol. 215, no. 6, pp. 492–504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Rong and M. Baudry, “Seizure activity results in a rapid induction of nuclear factor-κB in adult but not juvenile rat limbic structures,” Journal of Neurochemistry, vol. 67, no. 2, pp. 662–668, 1996. View at Google Scholar · View at Scopus
  34. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Okazaki, V. S. Ilea, A. Okazaki, K. Wicher, R. E. Reisman, and C. E. Arbesman, “Inhibition of antigen induced histamine release by ouabain,” The Journal of Allergy and Clinical Immunology, vol. 57, no. 5, pp. 454–462, 1976. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Ray and A. K. Samanta, “Receptor-mediated endocytosis of IL-8: a fluorescent microscopic evidence and implication of the process in ligand-induced biological response in human neutrophils,” Cytokine, vol. 9, no. 8, pp. 587–596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. S. K. Manna, Y. Sreenivasan, and A. Sarkar, “Cardiac glycoside inhibits IL-8-induced biological responses by downregulating IL-8 receptors through altering membrane fluidity,” Journal of Cellular Physiology, vol. 207, no. 1, pp. 195–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Takada, K. Matsuo, H. Ogura et al., “Odoroside A and ouabain inhibit Na+/K+-ATPase and prevent NF-κB-inducible protein expression by blocking Na+-dependent amino acid transport,” Biochemical Pharmacology, vol. 78, no. 9, pp. 1157–1166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon, “Dectin-1 mediates the biological effects of β-glucans,” The Journal of Experimental Medicine, vol. 197, no. 9, pp. 1119–1124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. V. le Cabec, S. Carréno, A. Moisand, C. Bordier, and I. Maridonneau-Parini, “Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively,” The Journal of Immunology, vol. 169, no. 4, pp. 2003–2009, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Ozinsky, D. M. Underhill, J. D. Fontenot et al., “The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13766–13771, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. M. N. Ajuebor, R. J. Flower, R. Hannon et al., “Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model,” Journal of Leukocyte Biology, vol. 63, no. 1, pp. 108–116, 1998. View at Google Scholar · View at Scopus
  43. T. Kawai and S. Akira, “Signaling to NF-κB by Toll-like receptors,” Trends in Molecular Medicine, vol. 13, no. 11, pp. 460–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. Q. Yang, W. Huang, C. Jozwik et al., “Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9631–9636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Forshammar, L. Block, C. Lundborg, B. Biber, and E. Hansson, “Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes,” Journal of Biological Chemistry, vol. 286, no. 36, pp. 31586–31597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Wang, M. Zheng, Z. Li et al., “Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition,” Cancer Research, vol. 69, no. 16, pp. 6556–6564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Hallett, A. E. Leitch, N. A. Riley, R. Duffin, C. Haslett, and A. G. Rossi, “Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation,” Trends in Pharmacological Sciences, vol. 29, no. 5, pp. 250–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. P. Hart, I. Dransfield, and A. G. Rossi, “Phagocytosis of apoptotic cells,” Methods, vol. 44, no. 3, pp. 280–285, 2008. View at Publisher · View at Google Scholar · View at Scopus